Log in

OTCMKTS:DDXS - diaDexus Stock Price, Forecast & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume67,400 shs
Average Volume15,481 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Diadexus, Inc is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:DDXS
CUSIP25245P106
Phone+1-650-2466400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive DDXS News and Ratings via Email

Sign-up to receive the latest news and ratings for DDXS and its competitors with MarketBeat's FREE daily newsletter.


diaDexus (OTCMKTS:DDXS) Frequently Asked Questions

What is diaDexus' stock symbol?

diaDexus trades on the OTCMKTS under the ticker symbol "DDXS."

How were diaDexus' earnings last quarter?

diaDexus, Inc. (OTCMKTS:DDXS) posted its quarterly earnings results on Monday, October, 26th. The company reported ($0.34) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.69) by $0.35. View diaDexus' Earnings History.

Has diaDexus been receiving favorable news coverage?

News articles about DDXS stock have trended somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. diaDexus earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for diaDexus.

What other stocks do shareholders of diaDexus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other diaDexus investors own include General Electric (GE), GoPro (GPRO), Ambarella (AMBA) and Alliqua Biomedical (ALQA).

Who are diaDexus' key executives?

diaDexus' management team includes the folowing people:
  • Lori F. Rafield Ph.D., Chairman of the Board, Chief Executive Officer (Age 60)
  • Leone D. Patterson, Chief Financial Officer (Age 54)
  • Emi Zychlinsky Ph.D., Executive Vice President, Chief Technology Officer (Age 59)
  • Christopher P Lowe, Chief Accounting Officer (Age 47)
  • Jonathan Ruais, Vice President of Marketing
  • Kenneth C. Fang M.D., Chief Medical Officer (Age 53)
  • R. Michael Richey, Chief Business Officer (Age 60)
  • James R. Sulat, Director (Age 66)
  • John T. Curnutte M.D. Ph.D., Independent Director (Age 65)
  • Karen Drexler, Independent Director (Age 56)

How do I buy shares of diaDexus?

Shares of DDXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is diaDexus' official website?

The official website for diaDexus is http://www.diadexus.com/.

How can I contact diaDexus?

diaDexus' mailing address is 349 Oyster Point Blvd, SOUTH SAN FRANCISCO, CA 94080-1947, United States. The company can be reached via phone at +1-650-2466400.


MarketBeat Community Rating for diaDexus (OTCMKTS DDXS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  129 (Vote Underperform)
Total Votes:  265
MarketBeat's community ratings are surveys of what our community members think about diaDexus and other stocks. Vote "Outperform" if you believe DDXS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DDXS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel